These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3257417)

  • 1. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response.
    Chanh TC; Kennedy RC; Kanda P
    Cell Immunol; 1988 Jan; 111(1):77-86. PubMed ID: 3257417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides.
    Cauda R; Tumbarello M; Ortona L; Kanda P; Kennedy RC; Chanh TC
    Cell Immunol; 1988 Aug; 115(1):57-65. PubMed ID: 3261206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide.
    Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC
    J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.
    Harris PE; Strba-Cechova K; Rubinstein P; Mann D; King DW; Suciu-Foca N
    J Clin Invest; 1990 Mar; 85(3):746-56. PubMed ID: 2312725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation.
    Chen YH; Christiansen A; Dierich MP
    Immunol Lett; 1995 Nov; 48(1):39-44. PubMed ID: 8847089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.
    Ruegg CL; Monell CR; Strand M
    J Virol; 1989 Aug; 63(8):3257-60. PubMed ID: 2526228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.
    Mann DL; Lasane F; Popovic M; Arthur LO; Robey WG; Blattner WA; Newman MJ
    J Immunol; 1987 Apr; 138(8):2640-4. PubMed ID: 3031162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
    Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.
    Kennedy RC; Henkel RD; Pauletti D; Allan JS; Lee TH; Essex M; Dreesman GR
    Science; 1986 Mar; 231(4745):1556-9. PubMed ID: 3006246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation.
    Cianciolo GJ; Bogerd H; Snyderman R
    Immunol Lett; 1988 Sep; 19(1):7-13. PubMed ID: 2973436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.
    Nair MP; Pottathil R; Heimer EP; Schwartz SA
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6498-502. PubMed ID: 3045818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
    Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
    J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor.
    Weigent DA; Hoeprich PD; Bost KL; Brunck TK; Reiher WE; Blalock JE
    Biochem Biophys Res Commun; 1986 Aug; 139(1):367-74. PubMed ID: 3094512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
    Blazevic V; Ranki A; Krohn KJ
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.